| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses | ||||||||
Research and development, net of tax credits (note 6) | ||||||||
46,092 | 41,985 | 35,133 | 29,499 | 21,523 | 16,849 | 0 | 0 | 0 |
General and administrative | ||||||||
8,728 | 7,004 | 5,941 | 4,483 | 3,592 | 3,052 | 0 | 0 | 0 |
Commercial | ||||||||
8,889 | 8,892 | 8,021 | 7,173 | 5,382 | 3,921 | 0 | 0 | 0 |
Loss from operations | ||||||||
-63,709 | -57,881 | -49,095 | -41,155 | -30,497 | -23,822 | 0 | 0 | 0 |
Interest income, net of bank charges | ||||||||
2,511 | 2,596 | 2,440 | 1,704 | 1,121 | 711 | 0 | 0 | 0 |
Loss and comprehensive loss before income taxes | ||||||||
-61,198 | -55,285 | -46,655 | -39,451 | -29,376 | -23,111 | 0 | 0 | 0 |
Income tax expense | ||||||||
- | -56 | 1 | 74 | 80 | 74 | 0 | 0 | 0 |
Net loss and comprehensive loss for the period | ||||||||
-61,120 | -55,229 | -46,656 | -39,525 | -29,456 | -23,185 | 0 | 0 | 0 |
Weighted average number of shares outstanding, basic and diluted | ||||||||
24,548 | 24,854 | 24,490 | 13,190 | 603 | 443 | 282 | 282 | 268 |
Net loss per share, basic and diluted (note 5) | ||||||||
-0.67 | 22.38 | -0.52 | -1.04 | -17.32 | 121.07 | -20.16 | -12.71 | -15.57 |